drugset / Trial / NCT01051531
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety, tolerability and treatment response of paliperidone palmitate administered as once-monthly injections to patients with schizophrenia.
Timeline
- Start
- 2010-04-22
- Primary completion
- 2013-05-17
- Completion
- 2013-05-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | paliperidone palmitate | Unknown | 50 mg | Intramuscular |
| Subject | paliperidone palmitate | Unknown | 75 mg | Intramuscular |
| Subject | paliperidone palmitate | Unknown | 100 mg | Intramuscular |
| Subject | paliperidone palmitate | Unknown | 150 mg | Intramuscular |